Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00561782 · ClinicalTrials.gov registry record
MR Spectroscopy as a Diagnostic and Outcome Measure in Pain and SCI
A clinical trial of Spinal Cord Injury and Hyperalgesia, Secondary, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- 94
- Enrollment target
- 1
- Study location
NCT00561782: Completed study of Spinal Cord Injury and Hyperalgesia, Secondary, sponsored by US Department of Veterans Affairs.
NCT00561782 is a study of Spinal Cord Injury and Hyperalgesia, Secondary that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 94 participants, above the 85-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (11% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00561782, a study of Spinal Cord Injury and Hyperalgesia, Secondary, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- 94 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to compare the changes that occur in sensation and chemical properties of the brain following SCI between individuals that experience chronic pain and those that do not, and between those with SCI and the able-bodied.
Conditions Studied
Study Locations (1)
Florida
- VA Medical Center, Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2007-10 |
| Est. Completion | 2010-11 |
What the finished NCT00561782 record still lists
NCT00561782 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 94 participants, a relatively small participant target, above the 85-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (11% higher).
The record links to 3 conditions, with Spinal Cord Injury appearing as the primary indexed condition, and to 0 interventions.
NCT00561782 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT00561782 about?
NCT00561782 is a clinical study titled "MR Spectroscopy as a Diagnostic and Outcome Measure in Pain and SCI". The goal of this study is to compare the changes that occur in sensation and chemical properties of the brain following SCI between individuals that experience chronic pain and those that do not, and between those with SCI and the able-bodied.
What is the current status of trial NCT00561782?
This trial is currently completed. The enrollment target is 94 participants. The study started on 2007-10. Estimated completion is 2010-11.
What conditions does trial NCT00561782 study?
This clinical trial studies the following conditions: Spinal Cord Injury, Hyperalgesia, Secondary, Hyperalgesic Sensations.
Who is sponsoring clinical trial NCT00561782?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00561782 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00561782's enrollment target sits among peer trials
94 19th of 99 higher than 80 of 99 other Spinal Cord Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cortical Recording and Stimulating Array Brain-Machine Interface
RECRUITING · NA
-
Clinical Outcome Assessment for AT & BCI
RECRUITING · NA
-
Motoneuron Recruitment and Motor Evoked Potential Up-Conditioning (MEP) in Spinal Cord Injury (SCI)
RECRUITING · NA
-
SCI&U Peer Health Coaching Program for Individuals Newly Discharged From Inpatient Rehabilitation
RECRUITING · NA
-
Spinal Cord Injury Registry - North American Clinical Trials Network
RECRUITING
-
Treating Central Neuropathic Pain With Low Dose Naltrexone for People With Spinal Cord Injury
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia